PENNSAID(R) Launch Brings New Treatment To Knee Osteoarthritis Patients
Links shared publicly online about this topic.
- 1,207total visits
PENNSAID(R) Launch Brings New Treatment To Knee Osteoarthritis Patients
Covidien (NYSE: COV), a leading global provider of healthcare products, has introduced PENNSAID® (diclofenac sodium topical solution) 1.5% w/w to the U.S. market. PENNSAID is the only FDA-appr
View full resource at medicalnewstoday.com
Tags: Bone, Osteoarthritis, Osteoarthritis Medication, Rheumatoid Arthritis Medication, Healthcare, NSAIDs, Voltaren, Cataflam
Most Recently Shared on April 28, 2010 at 1:11 pm By:
PENNSAID(R) Launch Brings New Treatment To Knee Osteoarthritis Patients http://mnt.to/3BPY #bones #orthopedics
Advertisement
